Lim CS - Search Results

1

Mapping the Evidence for Opioid-Mediated Changes in Malignancy and Chemotherapeutic Efficacy: Protocol for a Scoping Review.

Constance JE, McFarland MM, Casucci T, Deininger MW, Enioutina EY, Job K, Lemons RS, Lim CS, Ward RM, Yellepeddi V, Watt KM. Constance JE, et al. Among authors: lim cs. JMIR Res Protoc. 2023 May 22;12:e38167. doi: 10.2196/38167. JMIR Res Protoc. 2023. PMID: 37213193 Free PMC article.

2

Controlling subcellular localization to alter function: Sending oncogenic Bcr-Abl to the nucleus causes apoptosis.

Dixon AS, Kakar M, Schneider KM, Constance JE, Paullin BC, Lim CS. Dixon AS, et al. Among authors: lim cs. J Control Release. 2009 Dec 16;140(3):245-9. doi: 10.1016/j.jconrel.2009.06.026. Epub 2009 Jul 1. J Control Release. 2009. PMID: 19576252 Free PMC article.

3

Improved coiled-coil design enhances interaction with Bcr-Abl and induces apoptosis.

Dixon AS, Miller GD, Bruno BJ, Constance JE, Woessner DW, Fidler TP, Robertson JC, Cheatham TE 3rd, Lim CS. Dixon AS, et al. Among authors: lim cs. Mol Pharm. 2012 Jan 1;9(1):187-95. doi: 10.1021/mp200461s. Epub 2011 Dec 12. Mol Pharm. 2012. PMID: 22136227 Free PMC article.

4

Development of an effective therapy for chronic myelogenous leukemia.

Woessner DW, Lim CS, Deininger MW. Woessner DW, et al. Among authors: lim cs. Cancer J. 2011 Nov-Dec;17(6):477-86. doi: 10.1097/PPO.0b013e318237e5b7. Cancer J. 2011. PMID: 22157291 Free PMC article. Review.

5

Changing the subcellular location of the oncoprotein Bcr-Abl using rationally designed capture motifs.

Dixon AS, Constance JE, Tanaka T, Rabbitts TH, Lim CS. Dixon AS, et al. Among authors: lim cs. Pharm Res. 2012 Apr;29(4):1098-109. doi: 10.1007/s11095-011-0654-8. Epub 2011 Dec 20. Pharm Res. 2012. PMID: 22183511 Free PMC article.

6

Direct induction of apoptosis using an optimal mitochondrially targeted p53.

Mossalam M, Matissek KJ, Okal A, Constance JE, Lim CS. Mossalam M, et al. Among authors: lim cs. Mol Pharm. 2012 May 7;9(5):1449-58. doi: 10.1021/mp3000259. Epub 2012 Mar 28. Mol Pharm. 2012. PMID: 22380534 Free PMC article.

7

Selective targeting of c-Abl via a cryptic mitochondrial targeting signal activated by cellular redox status in leukemic and breast cancer cells.

Constance JE, Despres SD, Nishida A, Lim CS. Constance JE, et al. Among authors: lim cs. Pharm Res. 2012 Aug;29(8):2317-28. doi: 10.1007/s11095-012-0758-9. Epub 2012 May 2. Pharm Res. 2012. PMID: 22549737 Free PMC article.

8

Targeting malignant mitochondria with therapeutic peptides.

Constance JE, Lim CS. Constance JE, et al. Among authors: lim cs. Ther Deliv. 2012 Aug;3(8):961-79. doi: 10.4155/tde.12.75. Ther Deliv. 2012. PMID: 22946430 Free PMC article. Review.

9

Enhanced and selective killing of chronic myelogenous leukemia cells with an engineered BCR-ABL binding protein and imatinib.

Constance JE, Woessner DW, Matissek KJ, Mossalam M, Lim CS. Constance JE, et al. Among authors: lim cs. Mol Pharm. 2012 Nov 5;9(11):3318-29. doi: 10.1021/mp3003539. Epub 2012 Oct 12. Mol Pharm. 2012. PMID: 22957899 Free PMC article.

10

A coiled-coil mimetic intercepts BCR-ABL1 dimerization in native and kinase-mutant chronic myeloid leukemia.

Woessner DW, Eiring AM, Bruno BJ, Zabriskie MS, Reynolds KR, Miller GD, O'Hare T, Deininger MW, Lim CS. Woessner DW, et al. Among authors: lim cs. Leukemia. 2015 Aug;29(8):1668-75. doi: 10.1038/leu.2015.53. Epub 2015 Feb 27. Leukemia. 2015. PMID: 25721898 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,236 results

Search Page

Filters